Northern Trust Corp Gamida Cell Ltd. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.85 - $6.44 $47,971 - $80,242	-12,460 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.85 - $8.33 $50,672 - $72,154	-8,662 Reduced 41.01%	12,460 $80,000
Q1 2021 May 12, 2021	SELL	$7.8 - $12.43 $1,310 - $2,088	-168 Reduced 0.79%	21,122 $171,000
Q4 2020 Feb 11, 2021	BUY	$4.07 - $11.0 $11,827 - $31,966	2,906 Added 15.81%	21,290 $179,000
Q3 2020 Nov 16, 2020	BUY	$3.93 - $4.59 $2,935 - $3,428	747 Added 4.24%	18,384 $76,000
Q2 2020 Aug 14, 2020	BUY	$2.79 - $6.5 $49,207 - $114,640	17,637 New	17,637 $81,000

31.4K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.